Page last updated: 2024-10-29

imipramine and Porphyrias

imipramine has been researched along with Porphyrias in 2 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamal, S1
Grivois, H1
Goldberg, A1
Rimington, C1
Lochhead, AC1

Other Studies

2 other studies available for imipramine and Porphyrias

ArticleYear
[Acute porphyria, acute psychosis and psychotropic drugs. Apropos of a case].
    L'union medicale du Canada, 1985, Volume: 114, Issue:4

    Topics: Acute Disease; Adolescent; Humans; Imipramine; Male; Porphyrias; Psychoses, Substance-Induced; Psych

1985
Hereditary coproporphyria.
    Lancet (London, England), 1967, Mar-25, Volume: 1, Issue:7491

    Topics: Adult; Amino Acids; Anticonvulsants; Barbiturates; Biopsy; Bone Marrow Examination; Chlordiazepoxide

1967